Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

May 19, 2008 08:30 ET

Meridian Co., Ltd. Hires the Investor Relations Group

Active Investor and Media Outreach Commenced

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 19, 2008) - Meridian Co., Ltd. (OTCBB:MRDAF) (, a company engaged in the research, development, manufacturing, and sales of advanced medical devices, has retained the Investor Relations Group, Inc. ("IRG"), a thirteen-year-old, highly recognized corporate communications firm based in New York City, to serve as its national public relations and investor relations firm.

The Investor Relations Group's award-winning healthcare public relations department will reach out to the media-at-large, namely editors, writers, and producers of local and national trade and consumer online, print, radio, and broadcast media outlets, with the primary focus of educating the public about the potential products of Meridian. Simultaneously, IRG's investor relations team will use proprietary competitive analysis strategies and extensive databases to target the broad scope of the investment community, including portfolio managers and analysts. The program will include pre-qualified one-on-one introductions, e-mail to those that have opted-in for communication, and general traditional outreach.

"We remain focused on the expansion of our product line in an attempt to prevent illness, improve wellness, and promote worldwide health," commented Anna Brazier, Corporate Development Manager of Meridian Co., Ltd. "As we move forward with our vision to grow the company, the Investor Relations Group will play an integral part in communicating Meridian's message to the investment community and the public at large."

About The Investor Relations Group, Inc.

The Investor Relations Group, Inc. (IRG) offers a full-service corporate communications program designed to suit the many unique needs of Alternative Public Offering (APO) companies. The program utilizes a proprietary, targeted approach to reach institutional investors, analysts, and the media-at-large. For further information, please visit the company's website at

About Merdian Co., Ltd.

Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.

Safe Harbor Statement

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information

  • Meridian Co., Ltd.
    The Investor Relations Group
    Erika Moran/Tom Caden/Salima Rasul
    (212) 825-3210
    The Investor Relations Group
    Steven Melfi/Lynn Granito
    Public Relations
    (212) 825-3210